Almirall and absci announce ai drug discovery partnership to rapidly develop novel treatments for dermatological diseases

The collaboration expands absci's de novo ai drug creation portfolio into dermatology and accelerates discovery for broader chronic inflammatory diseases the collaboration expands absci's de novo ai drug creation portfolio into dermatology and accelerates discovery for broader chronic inflammatory diseases
ABSI Ratings Summary
ABSI Quant Ranking